Continuous glucose monitoring (CGM) devices are the latest advancement in the diabetes monitoring devices market, in which a sensor is linked to the CGM device and is placed on the patient’s skin. The device measures glucose levels in the interstitial fluid at frequent intervals and provides data which is captured via a transmitter to the receiver.
This report contains market size and forecasts of Continuous Glucose Monitoring Devices in Global, including the following market information:
Global Continuous Glucose Monitoring Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Continuous Glucose Monitoring Devices market was valued at 12690 million in 2021 and is projected to reach US$ 20650 million by 2028, at a CAGR of 7.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sensors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Continuous Glucose Monitoring Devices include Abbott Laboratories, Echo Therapeutics, Inc., Dexcom, Inc., GlySens Incorporated, Medtronic plc, Senseonics Holdings, Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd. and AgaMatrix, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Continuous Glucose Monitoring Devices companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Continuous Glucose Monitoring Devices Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Continuous Glucose Monitoring Devices Market Segment Percentages, by Type, 2021 (%)
Sensors
Transmitters & Receivers
Insulin Pumps
Global Continuous Glucose Monitoring Devices Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Continuous Glucose Monitoring Devices Market Segment Percentages, by Application, 2021 (%)
Diabetic Patients
Healthy Individuals
Global Continuous Glucose Monitoring Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Continuous Glucose Monitoring Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Continuous Glucose Monitoring Devices revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Continuous Glucose Monitoring Devices revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Echo Therapeutics, Inc.
Dexcom, Inc.
GlySens Incorporated
Medtronic plc
Senseonics Holdings, Inc.
Johnson & Johnson
F. Hoffmann-La Roche Ltd.
AgaMatrix, Inc.
Glucovation
GlySure
Arkray USA, Inc.
OrSense